Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa H Butterfield

Showing results (121-130 of 176) with videos related to

Pageof 18
Sort By:
Journal for Immunotherapy of Cancer|April 25, 2019
Multiple antigen-engineered DC vaccines with or without IFNα to promote antitumor immunity in melanomaLisa H Butterfield, Lazar Vujanovic, Patricia M Santos, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 5, 2008
Adenovirus MART-1-engineered autologous dendritic cell vaccine for metastatic melanomaLisa H Butterfield, Begonya Comin-Anduix, Lazar Vujanovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2003
Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanomaLisa H Butterfield, Antoni Ribas, Vivian B Dissette, et al.
Psychosomatic Medicine|April 6, 2018
Prospective Analyses of Cytokine Mediation of Sleep and Survival in the Context of Advanced CancerJennifer L Steel, Lauren Terhorst, Kevin P Collins, et al.
Journal of Translational Medicine|July 25, 2022
Co-expression of TNF receptors 1 and 2 on melanomas facilitates soluble TNF-induced resistance to MAPK pathway inhibitorsCindy A Sander, Elizabeth A Rush, Jian Shi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 30, 2010
Intratumoral IL-12 gene therapy results in the crosspriming of Tc1 cells reactive against tumor-associated stromal antigensXi Zhao, Anamika Bose, Hideo Komita, et al.
Journal for Immunotherapy of Cancer|August 27, 2020
The Great Debate at 'Immunotherapy Bridge', Naples, December 5, 2019Paolo A Ascierto, Carlo Bifulco, Jerome Galon, et al.
Cytotherapy|March 23, 2020
Accelerating the development of innovative cellular therapy products for the treatment of cancerMark D Stewart, Anne Keane, Lisa H Butterfield, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 18, 2004
Role of dendritic cell phenotype, determinant spreading, and negative costimulatory blockade in dendritic cell-based melanoma immunotherapyAntoni Ribas, John A Glaspy, Yohan Lee, et al.
Nature Medicine|September 20, 2022
Advancing T cell-based cancer therapy with single-cell technologiesSamantha L Bucktrout, Nicholas E Banovich, Lisa H Butterfield, et al.
Pageof 18

Showing results (121-130 of 176) with videos related to

Sort By:
Pageof 18
Journal for Immunotherapy of Cancer|April 25, 2019
Multiple antigen-engineered DC vaccines with or without IFNα to promote antitumor immunity in melanomaLisa H Butterfield, Lazar Vujanovic, Patricia M Santos, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 5, 2008
Adenovirus MART-1-engineered autologous dendritic cell vaccine for metastatic melanomaLisa H Butterfield, Begonya Comin-Anduix, Lazar Vujanovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2003
Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanomaLisa H Butterfield, Antoni Ribas, Vivian B Dissette, et al.
Psychosomatic Medicine|April 6, 2018
Prospective Analyses of Cytokine Mediation of Sleep and Survival in the Context of Advanced CancerJennifer L Steel, Lauren Terhorst, Kevin P Collins, et al.
Journal of Translational Medicine|July 25, 2022
Co-expression of TNF receptors 1 and 2 on melanomas facilitates soluble TNF-induced resistance to MAPK pathway inhibitorsCindy A Sander, Elizabeth A Rush, Jian Shi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 30, 2010
Intratumoral IL-12 gene therapy results in the crosspriming of Tc1 cells reactive against tumor-associated stromal antigensXi Zhao, Anamika Bose, Hideo Komita, et al.
Journal for Immunotherapy of Cancer|August 27, 2020
The Great Debate at 'Immunotherapy Bridge', Naples, December 5, 2019Paolo A Ascierto, Carlo Bifulco, Jerome Galon, et al.
Cytotherapy|March 23, 2020
Accelerating the development of innovative cellular therapy products for the treatment of cancerMark D Stewart, Anne Keane, Lisa H Butterfield, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 18, 2004
Role of dendritic cell phenotype, determinant spreading, and negative costimulatory blockade in dendritic cell-based melanoma immunotherapyAntoni Ribas, John A Glaspy, Yohan Lee, et al.
Nature Medicine|September 20, 2022
Advancing T cell-based cancer therapy with single-cell technologiesSamantha L Bucktrout, Nicholas E Banovich, Lisa H Butterfield, et al.
Pageof 18